Do Blood Cell Parameters have a Predictive Role in the Etiology and Severity Pediatric Antrochoanal Polyp Cases?

Müge Özçelik Korkmaz1, Bilgehan Çelik1, Fatih Turan1

  • 1Department of Otolaryngology, Sakarya University Medical Faculty, Korucuk, Sakarya, Turkey.

Insights

Blood cell distribution parameters, like mean platelet volume (MPV) and platelet-to-lymphocyte ratio (PLR), may indicate severity and recurrence risk in pediatric antrochoanal polyps (ACPs). Further research is needed to establish definitive diagnostic parameters.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Hematology

Background:

  • Pediatric antrochoanal polyps (ACPs) lack definitive parameters for etiology and severity assessment.
  • Understanding factors influencing ACPs is crucial for effective management and predicting outcomes.

Purpose of the Study:

  • To compare blood cell distribution parameters in pediatric ACP patients versus a control group.
  • To identify potential biomarkers for determining ACP etiology, severity, and recurrence risk.

Main Methods:

  • Retrospective analysis of blood count values from pediatric ACP patients and a matched control group.
  • Statistical comparison of blood parameters, including mean platelet volume (MPV) and platelet-to-lymphocyte ratio (PLR), across different ACP severity and recurrence subgroups.

Main Results:

  • No significant difference in blood cell distribution parameters between the overall ACP group and the control group.
  • Stage III ACP patients and those with recurrence showed significantly higher MPV and PLR values compared to controls.
  • These findings suggest a potential link between specific inflammatory markers and ACP severity/recurrence.

Conclusions:

  • Inflammatory parameters, specifically MPV and PLR, may vary with disease severity and recurrence in pediatric ACPs.
  • These parameters show potential as guiding indicators for ACP management and prognosis.
  • Further investigation is warranted to validate these findings and establish clinical utility.